Candel Therapeutics (CADL) Non-cash Items (2020 - 2025)

Candel Therapeutics has disclosed Non-cash Items across 6 years of filings, most recently posting $13.7 million for Q4 2025.

• Non-cash Items for Q4 2025 came in at $13.7 million, down 50.38% year-over-year; the trailing twelve-month figure through Dec 2025 was $13.7 million (down 50.38% YoY), and the FY2025 annual result was $13.7 million, down 50.38% from the prior year.
• Non-cash Items came in at $13.7 million for Q4 2025 at Candel Therapeutics, up from $3.9 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $27.6 million in Q4 2024 to a low of $199000.0 in Q4 2023.
• The 5-year median for Non-cash Items is $3.4 million (2024), against an average of $6.8 million.
• Peak annual rise in Non-cash Items reached 13768.84% in 2024, while the deepest fall reached 94.6% in 2024.
• Candel Therapeutics' Non-cash Items stood at $2.1 million in 2021, then slumped by 57.07% to $881000.0 in 2022, then sank by 77.41% to $199000.0 in 2023, then jumped by 13768.84% to $27.6 million in 2024, then plunged by 50.38% to $13.7 million in 2025.
• The last three Non-cash Items figures came in at $13.7 million (Q4 2025), $3.9 million (Q3 2025), and $11.3 million (Q2 2025), per Business Quant data.